Pharmacogenomics of methadone: a narrative review of the literature.
Pharmacogenomics
Packiasabapathy, Senthil S; Aruldhas, Blessed W BW; Horn, Nicole N; Overholser, Brian R BR; Quinney, Sara K SK; Renschler, Janelle S JS; Sadhasivam, Senthilkumar S
Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.
Clinical Pharmacology And Therapeutics
Burgess, Kimberly S KS; Ipe, Joseph J; Swart, Marelize M; Metzger, Ingrid F IF; Lu, Jessica J; Gufford, Brandon T BT; Thong, Nancy N; Desta, Zeruesenay Z; Gaedigk, Roger R; Pearce, Robin E RE; Gaedigk, Andrea A; Liu, Yunlong Y; Skaar, Todd C TC
Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.